Trademark Overview
On Wednesday, December 24, 2008, a trademark application was filed for JENDO with the United States Patent and Trademark Office. The USPTO has given the JENDO trademark a serial number of 77639611. The federal status of this trademark filing is ABANDONED - EXPRESS as of Thursday, January 29, 2009. This trademark is owned by Glaxo Group Limited. The JENDO trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines